» Articles » PMID: 36490315

The BRCA1 BRCT Promotes Antisense RNA Production and Double-stranded RNA Formation to Suppress Ribosomal R-loops

Overview
Specialty Science
Date 2022 Dec 9
PMID 36490315
Authors
Affiliations
Soon will be listed here.
Abstract

R-loops, or RNA:DNA hybrids, can induce DNA damage, which requires DNA repair factors including breast cancer type 1 susceptibility protein (BRCA1) to restore genomic integrity. To date, several pathogenic mutations have been found within the tandem BRCA1 carboxyl-terminal (BRCT) domains that mediate BRCA1 interactions with proteins and DNA in response to DNA damage. Here, we describe a nonrepair role of BRCA1 BRCT in suppressing ribosomal R-loops via two mechanisms. Through its RNA binding and annealing activities, BRCA1 BRCT facilitates the formation of double-stranded RNA between ribosomal RNA (rRNA) and antisense-rRNA (as-rRNA), hereby minimizing rRNA hybridization to ribosomal DNA to form R-loops. BRCA1 BRCT also promotes RNA polymerase I-dependent transcription of as-rRNA to enhance double-stranded rRNA (ds-rRNA) formation. In addition, BRCA1 BRCT-mediated as-rRNA production restricts rRNA maturation in unperturbed cells. Hence, impairing as-rRNA transcription and ds-rRNA formation due to BRCA1 BRCT deficiency deregulates rRNA processing and increases ribosomal R-loops and DNA breaks. Our results link ribosomal biogenesis dysfunction to BRCA1-associated genomic instability.

Citing Articles

Conserved GTPase OLA1 promotes efficient translation on D/E-rich mRNA.

Yu T, Li X, Dong W, Zhou Q, Li Q, Du Z Nat Commun. 2025; 16(1):1549.

PMID: 39934121 PMC: 11814078. DOI: 10.1038/s41467-025-56797-8.


DDX41: exploring the roles of a versatile helicase.

Winstone L, Jung Y, Wu Y Biochem Soc Trans. 2024; 52(1):395-405.

PMID: 38348889 PMC: 10903454. DOI: 10.1042/BST20230725.


MoDAFold: a strategy for predicting the structure of missense mutant protein based on AlphaFold2 and molecular dynamics.

Zheng L, Shi S, Sun X, Lu M, Liao Y, Zhu S Brief Bioinform. 2024; 25(2).

PMID: 38305456 PMC: 10835750. DOI: 10.1093/bib/bbae006.


Targeting the / deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights.

Ragupathi A, Singh M, Perez A, Zhang D Front Cell Dev Biol. 2023; 11:1133472.

PMID: 37035242 PMC: 10073599. DOI: 10.3389/fcell.2023.1133472.

References
1.
Fan S, Wang J, Yuan R, Ma Y, Meng Q, Erdos M . BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science. 1999; 284(5418):1354-6. DOI: 10.1126/science.284.5418.1354. View

2.
Tulchin N, Chambon M, Juan G, Dikman S, Strauchen J, Ornstein L . BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines. Am J Pathol. 2010; 176(3):1203-14. PMC: 2832143. DOI: 10.2353/ajpath.2010.081063. View

3.
Nair S, Zhang X, Chiang H, Jahid M, Wang Y, Garza P . Genetic suppression reveals DNA repair-independent antagonism between BRCA1 and COBRA1 in mammary gland development. Nat Commun. 2016; 7:10913. PMC: 4785232. DOI: 10.1038/ncomms10913. View

4.
Park D, Bergin S, Jones D, Ru P, Koivisto C, Jeon Y . Ablation of the Brca1-Palb2 Interaction Phenocopies Fanconi Anemia in Mice. Cancer Res. 2020; 80(19):4172-4184. DOI: 10.1158/0008-5472.CAN-20-0486. View

5.
Chang C, Xu X, Li M, Xin D, Ding L, Wang Y . Pathogenic mutations reveal a role of RECQ4 in mitochondrial RNA:DNA hybrid formation and resolution. Sci Rep. 2020; 10(1):17033. PMC: 7552406. DOI: 10.1038/s41598-020-74095-9. View